1. Cnotliwy M., Jastrzębska M., Wiernicki I., Chełstowski K.: Coagulation and fibrinolysis in
the abluminal layer of the thrombus within abdominal aortic aneurysm. Acta Angiol. 2007,
13, 114-121.
2. Mierzecki A., Makarewicz-Wujec M., Bukowska H., Honczarenko K., Jastrzębska M.,
Chełstowski K., Kozłowska-Wojciechowska M.: Selected dietary atherosclerosis risk
factors in offspring of patients with premature ischemic stroke. Pol. Merkuriusz Lek.,
2008, 24, 511-515
3. Jastrzębska M, Chełstowski K, Mierzecki A., Klimek K, Bukowska H.: Effects of
fenofibrate treatment on the prothrombotic state in patients with metabolic syndrome in
relation to the smoking status and diabetes. Med. Sci. Monit. 2009, 15, 27-33
4. Mierzecki A., Kozłowska-Wojciechowska M., Bukowska H., Makarewicz-Wujec M.,
Honczarenko K., Chełstowski K., Jastrzębska M., Masztalewicz M.: Does the progeny of
premature ischemic stroke sufferers need intensive interest of physicians oriented toward
primary prevention/ A pilot study. Eur. J. Cardiovasc. Prev. Rehabil., 2010, 17, 725-729.
5. Jastrzębska M., Siennicka A., Chełstowski K., Ciechanowicz A., Nowacki P., Wódecka
A.: Laboratory evaluation of the response to ASA treatment in patients in acute phase of
ischemic stroke – application of flow (PFA-100) and impedance (Multiplate)
aggregometry. Diagn. Lab., 2011, 47, 155-163.
6. Jastrzębska M., Chełstowski K., Siennicka A., Grzelec H., Bajer-Czajkowska a., Rybicka
M., Ckark J., Nowacki P.: The character of haemostatic disorders and level of protein-100
in acute ischaemic stroke can affect survival in the first week of follow-up; a pilot study.
Blood Coagul. Fibrinolysis, 2011, 22, 388-395.
7. Mierzecki a., Kłoda K., Jastrzębska M., Chełstowski K., Honczarenko K., KozlowskaWojciechowska M., Naruszewicz M.: Is the an effect of folic acid supplementation on the
coagulation factors and C-reactive protein concentrations in subjects with atherosclerosis
risk factors? Post.Hig. 2012, 66, 696-701.
8. Siennicka A., Drożdżyńska M., Chełstowski K., Cnotliwy M., Jastrzębska M.: Haemostatic
factors and intraluminal thrombus in abdominal aortic aneurysm. Is secondary fibrinolysis
relevant?. J. Physiol. Pharmacol., 2013, 64, 321-330.
9. Jastrzębska M., Chełstowski K., Wódecka A., Siennicka A., Clark J., Nowacki P.: Factors
influencing Multiplate whole blood Impedance Platelet Aggregometry measurements
during aspirin treatment in acute ischemic stroke: a pilot study. Blood Coagul.
Fibrinolysis. 2013, 24, 830-838.
10. Kucharska-Mazur J., Tarnowski M., Dołęgowska B., Budkowska M., Pędziwiatr D.,
Jabłoński M., Pełka-Wysiecka J., Kazimierczak A., Ratajczak M.Z., Samochowiec J.:
Novel evidence for enhanced stem cell trafficking in antipsychotic-naive subjects during
their first psychotic episode.J. Psychiatr. Res. 2014, Epub ahead of print
11. Błogowski W., Dołęgowska B., Budkowska M., Sałata M., Domański L., Starzyńska T.:
Perioperative release of pro-regenerative biochemical signals from human renal
allografts subjected to ischemia-reperfusion injury. Innate Immun. 2014, Epub ahead of
print
12. Starzyńska T., Dąbkowski K., Błogowski W., Zuba-Surma E., Budkowska M., Sałata D.,
Dołęgowska B., Marlicz W., Lubikowski J., Ratajczak M.Z.: An intensified systemic
trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic
cancer. J. Cell. Mol. Med. 2013, 17, 792-799.
13. Błogowski W., Budkowska M., Sałata D., Serwin K., Dołegowska B., Łokaj M., Prowans
P., Starzyńska T.: Clinical analysis of selected complement-derived molecules in human
adipose tissue. J. Translat. Med. 2013, 11, 13 s.
14. Lubkowska A., Dołęgowska B., Szyguła Z., Bryczkowska I., Stańczyk-Dunaj M., Sałata
D., Budkowska M.: Winter-swimming as a building-up body resistance factor inducing
adaptive changes in the oxidant/antioxidant status. Scand. J. Clin. Lab. Invest. 2013, 73,
315-325.
15. Błogowski W., Ratajczak M.Z., Żyżniewska-Banaszak E., Dołęgowska B., Starzyńska T.:
Adipose tissue as a potential source of hematopoietic stem/progenitor cells. Obesity
(Silver Spring). 2012, 20, 923-931.
16. Dołęgowska B., Błogowski W., Domański L.: Association between the perioperative
antioxidative ability of platelets and early post-transplant function of kidney allograftsa
pilot study. PLoS One. 2012, 7, e29779, 7 s.
17. Błogowski W., Dołęgowska B., Sałata D., Budkowska M., Domański L., Starzyńska T.:
Clinical analysis of perioperative complement activity during ischemia/reperfusion injury
following renal transplantation. Clin. J. Am. Soc. Nephrol. 2012, 7, 1843-1851.
18. Błogowski W., Serwin K., Budkowska M., Sałata D., Dołęgowska B., Łokaj M., Prowans
P., Starzyńska T.: Clinical analysis of systemic and adipose tissue levels of selected
hormones/adipokines and stromal-derived factor-1. J. Biol. Regul. Homeost. Agents.
2012, 26, 607-615.
19. Lubkowska A., Dołęgowska B., Banfi G.: Growth factor content in PRP and their
applicability in medicine. J. Biol. Regul. Homeost. Agents. 2012, 26, 3(S)-22(S).
20. Błogowski W., Serwin K., Sałata D., Budkowska M., Dołęgowska B., Łokaj M., Prowans
P., Starzyńska T.: Plasma and adipose tissue levels of selected growth/inhibitory factors,
proteolytic enzymes and sphingosine-1-phosphate in humans. Eur. J. Inflamm. 2012, 10,
279-288.
21. Dołęgowska B., Lubkowska A., De Girolamo L.: Platelet lipidomic. J. Biol. Regul.
Homeost. Agents. 2012, 26, 23(S)-33(S).
22. Dołegowska B., Błogowski W., Stępniewska J., Safranow K., Jakubowska K., Olszewska
M.: Presence of glucose in dialyzing fluid and synthesis of selected lipoxygenase-derived
eicosanoids during hemodialysis. Int. Urol. Nephrol. 2012, 44, 1799-1804.
23. Ostapowicz A., Dołęgowska B.: Przegląd metod oznaczania dehydrogenazy
dihydropirymidynowej oraz możliwości ich zastosowania w badaniach przesiewowych
poprzedazjących chemoterapię 5-fluorouracylem. Prz. Lek. 2012, 69, 694-697.
24. Sałata D., Budkowska M., Dołęgowska B.: Sfingozyno-1-fosforan - dyrygent wśród
cząsteczek. Post. Bioch. 2012, 58, 281-291.
25. Dołęgowska B., Ostapowicz A., Stańczyk-Dunaj M., Błogowski W.: Spectrophotometric
methods as a novel screening approach for analysis of dihydropirimidine
dehydrodrogenase activity before treatment with 5-fluorouracil chemotherapy. J. Physiol.
Pharmacol. 2012, 63, 411-421.
26. Błogowski W., Dołęgowska B., Pikuła E., Gutowski P., Starzyńska T.: The effect of PGE
administration on the activity of oxidative system in erythrocytes and platelets during
ischemia reperfusion injury and on postoperative renal function in patients undegoing
open abdominla aortic aneurysm reconstruction. J. Biol. Regul. Homeost. Agents. 2012,
26, 429-438.
27. Lubkowska A., Dołegowska B., Szyguła Z.: Whole-body cryostimulation - potential
beneficial treatment for improving antioxidant capacity in healthy men - significance of the
number of sessions. PLoS One. 2012, 7, e46352, 10 s.
28. Kędzierska K., Doma©ski L., Sporniak-Tutak K., Dołęgowska B., Ciechanowski K.:
Oxidative stress and renal interstitial fibrosis in patients after renal transplantation current
state of knowledge. Transplant. Proc. 2011, 43, 3577-3583.
29. Kędzierska K., Sporniak-Tutak K., Bober J., Safranow K., Olszewska M., Jakubowska K.,
Domański L., Gołembiewska E., Kwiatkowska E., Laszczyńska M., Dołęgowska B.,
Ciechanowski K.: Oxidative stress indices in rats under immunosuppression. Tranplant.
Proc. 2011, 43, 3939-3945.
30. Dudzińska W., Lubkowska A., Dołęgowska B., Safranow K., Jakubowska K.: Adenine,
guanine and pyridine nucleotides in blood during physical exercise and restitution in
healthy subjects. Eur. J. App. Physiol. 2010, 110, 1135-1162.
31. Dudzińska W., Lubkowska A., Dołegowska B., Safranow K.: Blood uridine concentration
may be an indicator of the degradation of pyrimidine nucleotides during physical exercise
with increasing intensity. J. Physiol. Biochem. 2010, 66, 189-196.
32. Lubkowska A., Banfi G., Dołęgowska B., d’Eril G.V.M., Łuczak J., Barassi A.: Changes in
lipid profile in response to three different protocols of whole-body cryostimulation
treatments. Cryobiology. 2010, 61, 22-26.
33. Dołęgowska B., Błogowski W., Domański L.: Clinical evidence of the association between
serum perioperative changes in xanthine metabolizing enzymes activity and early posttransplant kidney allograft function. J. Am. Coll. Surg. 2010, 211, 587-595.
34. Dołęgowska B., Błogowski W., Safranow K., Jakubowska K., Olszewska M.:
Lipoxygenase-derived hydroxyeicosatetraenoic acids--novel perioperative markers of
early post-transplant allograft function? Nephrol. Dial. Transplant. 2010, 25, 4061-4071.
35. Kwiatkowska E., Kędzierska K., Bober J., Dołęgowska B., Dziedziejko V., Gołembiewska
E., Ciechanowski K., Wiśniewska M.: Urinary hepatocyte growth factor indicates
ischemia/reperfusion injury after kidney transplantation. = Czynnik wzrostu hepatocytów
w moczu wskaźnikiem uszkodzenia nerki w procesie niedokrwienia i reperfuzji w
przeszczepionej nerce. Pol. Arch. Med. Wew. 2010, 120, 437-443.
36. Lubkowska A., Dołęgowska B., Szygula Z., Klimek A.: Activity of selected enzymes in
erythrocytes and level of plasma antioxidants in response to single whole-body
cryostimulation in humans. Scand. J. Clin. Lab. Invest. 2009, 69, 387-394.
37. Dołęgowska B., Błogowski W., Domański L.: Dynamics of thromboxane level changes
during early phase of allograft reperfusion. Clin Transplant. 2009, 23, 716-722.
38. Dołęgowska B., Blogowski W., Domański L.: Is it possible to predict the early posttransplant allograft function using 20-HETE measurements? A preliminary report.
Transpl. Int. 2009, 22, 546-553.
39. Kwiatkowski S., Torbe A., Dołęgowska B., Błogowski W., Czajka R., Chlubek D., Rzepka
R.: Isoprostanes 8-iPF2alpha-IIIrisk markers of premature rupture of fetal membranes?
Biomarkers. 2009, 14, 406-413.
40. Dołęgowska B., Błogowski W., Kędzierska K., Safranow K., Jakubowska K., Olszewska
M., Rać M., Chlubek D., Ciechanowski K.: Platelets arachidonic acid metabolism in
patients with essential hypertension. Platelets. 2009, 20, 242-249.